MN
Manju Narahari
About Manju Narahari
Data last updated:
Manju Narahari is a Director at Erotas Life Sciences Private Limited (since 2023). Erotas Life Sciences Private Limited reported revenue of ₹23.8 Lakh (FY 2025). Earlier, Manju Narahari was a Director at Novakind Healthcare Private Limited (from 2013).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 23 Jun 2023 | 2023 | ₹23.8 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 12 Feb 2013 | 2013 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Manju Narahari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Asis Kumar Behera | 05216237 | Erotas Life Sciences Private Limited | Director |
| Nyapati Venkata Satya Giridhar | 00848854 | Erotas Life Sciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manju Narahari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manju Narahari
Manju Narahari currently holds 1 directorship: Erotas Life Sciences Private Limited (Director, since 23 Jun 2023, revenue ₹23.8 Lakh (FY 2025)).
Manju Narahari was first appointed on 12 Feb 2013 as Director at Novakind Healthcare Private Limited. The most recent appointment on record is 23 Jun 2023 at Erotas Life Sciences Private Limited.
Manju Narahari held 1 earlier board appointment: Novakind Healthcare Private Limited (Director, from 12 Feb 2013).
The current boards of Manju Narahari's companies include Asis Kumar Behera (Erotas Life Sciences Private Limited), Nyapati Venkata Satya Giridhar (Erotas Life Sciences Private Limited).